IRIS
COLPANI, Agnese
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.774
AS - Asia 903
EU - Europa 545
SA - Sud America 520
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.786
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.720
BR - Brasile 458
SG - Singapore 408
CN - Cina 146
DE - Germania 136
IT - Italia 126
VN - Vietnam 106
FI - Finlandia 99
HK - Hong Kong 80
FR - Francia 46
AR - Argentina 30
CA - Canada 27
GB - Regno Unito 27
RU - Federazione Russa 22
BD - Bangladesh 20
IN - India 18
TR - Turchia 16
ES - Italia 14
IQ - Iraq 14
MX - Messico 13
PK - Pakistan 13
JP - Giappone 12
MA - Marocco 12
VE - Venezuela 11
PL - Polonia 9
UZ - Uzbekistan 9
AT - Austria 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
AE - Emirati Arabi Uniti 7
ID - Indonesia 7
UA - Ucraina 7
ZA - Sudafrica 7
AZ - Azerbaigian 6
BE - Belgio 6
JM - Giamaica 6
KR - Corea 6
NL - Olanda 6
SE - Svezia 6
KE - Kenya 5
LT - Lituania 5
CO - Colombia 4
EG - Egitto 4
JO - Giordania 4
KG - Kirghizistan 4
LB - Libano 4
SA - Arabia Saudita 4
BG - Bulgaria 3
IL - Israele 3
NP - Nepal 3
PS - Palestinian Territory 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IE - Irlanda 2
KZ - Kazakistan 2
MK - Macedonia 2
MT - Malta 2
MY - Malesia 2
MZ - Mozambico 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
SR - Suriname 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 3.786
Salva come PNG Salva come JPEG
Città #
Dallas 991
Singapore 217
San Jose 166
Munich 102
Ashburn 97
Hong Kong 79
Helsinki 77
New York 62
Beijing 51
Los Angeles 49
São Paulo 40
Lauterbourg 33
Ho Chi Minh City 32
Chandler 23
Hanoi 23
Shanghai 19
Palermo 17
Rio de Janeiro 16
Council Bluffs 13
Santa Clara 13
Denver 12
Montreal 12
Atlanta 11
Frankfurt am Main 11
Tokyo 11
Belo Horizonte 10
Milan 10
Rome 9
Turku 9
Brno 8
Chennai 8
Chicago 8
Lahore 8
Nuremberg 8
Orem 8
Porto Alegre 8
San Francisco 8
Baghdad 7
Brasília 7
Brooklyn 7
Buffalo 7
Haiphong 7
São José dos Campos 7
Warsaw 7
Campinas 6
Falkenstein 6
Guarulhos 6
Houston 6
Lappeenranta 6
Seoul 6
Tashkent 6
Ankara 5
Baku 5
Boston 5
Brussels 5
Cagliari 5
Düsseldorf 5
Fortaleza 5
London 5
Nairobi 5
Santo André 5
Sassari 5
Stockholm 5
Toronto 5
Amman 4
Bishkek 4
Contagem 4
Curitiba 4
Da Nang 4
Dhaka 4
Florianópolis 4
Guayaquil 4
Jyväskylä 4
Kingston 4
Madrid 4
New Delhi 4
Recife 4
Vienna 4
Biên Hòa 3
Boardman 3
Bogotá 3
Buenos Aires 3
Campos dos Goytacazes 3
Caruaru 3
Casablanca 3
City of London 3
Duque de Caxias 3
Florence 3
Hortolândia 3
Imbituba 3
Ipatinga 3
Johannesburg 3
Manaus 3
Manchester 3
Maracaibo 3
Mexico City 3
Montevideo 3
Monza 3
Mountain View 3
Phoenix 3
Totale 2.557
Salva come PNG Salva come JPEG
Nome #
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 571
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 263
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 153
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 138
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 130
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 129
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 129
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 128
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 115
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 115
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 110
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 107
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 107
What do We Know about Cryptic Aspergillosis? 105
Living with HIV and Getting Vaccinated: A Narrative Review 105
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 100
The current and future off-label uses of dalbavancin: a narrative review 98
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 96
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 88
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 87
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 86
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 84
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 78
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 77
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 75
Incidence and burden of long COVID in Africa: a systematic review and meta-analysis 64
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's response 62
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free 62
Special Issue "Efficacy and Safety of Antiviral Therapy" 57
Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data 54
The high burden of pediatric cystic echinococcosis in Kazakhstan: epidemiological and clinical consequences 49
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better? 40
Bictegravir/emtricitabine/tenofovir alafenamide in people with HIV aged ≥50: low discontinuation rates and favorable metabolic outcomes over 36 months 30
Present and future of HIV pre-exposure prophylaxis: a narrative review 26
Phage to ESKAPE: Personalizing Therapy for MDR Infections—A Comprehensive Clinical Review 25
Long-acting CAB + RPV: safety, efficacy, and discontinuation risks in ODOACRE cohort 22
Is ChatGPT-4 accurate and complete when answering questions on tuberculosis? Results of the ChatGTB study 21
Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV 17
Use of Tobacco and Alternative Nicotine Products Among People with HIV: A Cross-Sectional Multicenter Survey 16
Risk of autochthonous human schistosomiasis transmission in Italy 13
Ultrasound-based population survey for abdominal cystic echinococcosis in Albania: Results from the NDTND project 10
Totale 3.842
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202368 0 7 2 6 4 15 3 4 3 9 9 6
2023/2024167 11 8 10 6 52 31 3 5 1 2 14 24
2024/20251.200 26 6 62 37 28 64 141 234 377 150 52 23
2025/20262.407 94 397 734 254 241 100 261 61 83 123 35 24
Totale 3.842